Effects of intestine-specific deletion of FGF15 on the development of fatty liver disease with vertical sleeve gastrectomyMonica D. Chow, Grace L. Guo, Brian Buckley et al.|Hepatology Communications|2024Cited by 8
An Industry Perspective on Key Considerations for the ICH S13 Guidance: Nonclinical Safety Evaluations of Oligonucleotide-Based TherapeuticsJennifer D. Sisler, Tod A. Harper, Yi Yang et al.|International Journal of Toxicology|2026Cited by 1